Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

Status Completed

Clinical Trial Summary

The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.

Clinical Trial Description

This will be a randomized, evaluator-blind, single-center, controlled, within-subject comparison study of the investigational products (abametapir lotion) and its vehicle lotion and positive and negative controls under occlusive conditions in healthy volunteers. All subjects will have the investigational product (abametapir lotion), the vehicle product, the positive control patch, and negative control patch applied to 4 randomly assigned, adjacent skin sites on the infrascapular area of their back, for the purpose of determining irritation potential. The investigational products, vehicle, and controls will be applied to one side of the infrascapular area of the back. Evaluation of dermal reactions at the application sites will be assessed clinically using a visual scale that rates the degree of erythema, edema, and other signs of cutaneous irritation (see Section 3.5.5). A total of 21 applications of each product will be made. ;

Study Design

Related Conditions & MeSH terms

Head Lice

Clinical Trial Details

NCT number	NCT02061813
Study type	Interventional
Source	Dr. Reddy's Laboratories Limited
Contact
Status	Completed
Phase	Phase 1
Start date	January 2014
Completion date	May 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00988533` - A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age	Phase 1
Completed	`NCT00672971` - Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice	N/A
Completed	`NCT00858481` - A Pilot Dose Ranging Study of Spinosad Creme Rinse	Phase 2
Completed	`NCT03301649` - Clinical Endpoint Study of Ivermectin 0.5% Lotion	Phase 3
Completed	`NCT00994422` - Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects	Phase 2
Completed	`NCT00995124` - Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application	Phase 4
Completed	`NCT03337490` - A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice	Phase 3
Completed	`NCT06333054` - Safety and Efficacy of a Head Lice Shampoo	N/A
Completed	`NCT02213055` - Pediatric Head Lice Study Product Comparison	Phase 2
Completed	`NCT02974088` - Neem Lotion With Combing for Lice	Phase 2
Recruiting	`NCT05379114` - Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation	N/A
Completed	`NCT03617926` - A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.	N/A
Completed	`NCT01803581` - A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice	N/A
Completed	`NCT01068158` - A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects	Phase 3
Completed	`NCT01066585` - A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation	Phase 3
Completed	`NCT00857935` - A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse	Phase 2
Completed	`NCT00301340` - Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice	Phase 3
Completed	`NCT02062073` - Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion	Phase 1
Completed	`NCT00605956` - NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers	Phase 1
Completed	`NCT00301327` - Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.	Phase 3